Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes
- PMID: 32360710
- PMCID: PMC7251996
- DOI: 10.1016/j.diabres.2020.108185
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes
Abstract
Diabetes emerged as major risk factor for severe acute respiratory syndrome (SARS) and adverse outcome in patients with the coronavirus disease 2019 (COVID-19). Nevertheless, the role of admission hyperglycemia in patients with COVID-19 has not been well-explored, yet. With this retrospective analysis, we report for the first time that hyperglycemia on day-1 is the best predictor of radiographic imaging of SARS-CoV2, regardless of the past medical history of diabetes. Admission hyperglycemia should not be overlooked, but adequately treated to improve the outcomes of COVID-19 patients with our without diabetes.
Keywords: COVID-19; Diabetes; Hyperglycemia; SARS-Cov2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Figures


References
-
- Remuzzi A, Remuzzi, G. COVID-19 and Italy: what next? Lancet; 2020 https://doi.org/10.1016/S0140-6736(20)30627-9. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous